Abstract
The current review discusses the different synthetic pathways for one of the most important and interesting heterocyclic ring systems, 1,4-dihydropyridine. This cyclic system depicts diverse pharmacological action on several receptors, channels, and enzymes. Dihydropyridine moiety plays an important role in several calcium-channel blockers. Moreover, it has been exploited for the treatment of a variety of cardiovascular diseases due to its potential antihypertensive, anti-angina, vasodilator, and cardiac depressant activities. Furthermore, it also shows antibacterial, anticancer, anti-leishmanial, anticoagulant, anticonvulsant, anti-tubercular, antioxidant, antiulcer, and neuroprotective properties. Several reports have demonstrated dihydropyridine derivatives as a potentiator of cystic fibrosis transmembrane conductance regulator protein, potent antimalarial agent and HIV-1 protease inhibitor. Herein, we have briefly reviewed different novel chemistry and the synthesis of 1,4-dihydropyridine.
Keywords: Dihydropyridine, anticancer, anti-tubercular, ionizing radiation, anti-leishmanial, HIV-1.
[http://dx.doi.org/10.2174/1389557513666131119204126 PMID: 24251802]
[http://dx.doi.org/10.1021/cr60275a001]
[http://dx.doi.org/10.1021/jo00915a011]
[http://dx.doi.org/10.1021/cr00048a004]
[http://dx.doi.org/10.1021/jo9623301]
[http://dx.doi.org/10.1139/v82-187]
[http://dx.doi.org/10.1021/ja00715a040] [PMID: 5422774]
[http://dx.doi.org/10.3109/03008200009067665 PMID: 10992159]
[http://dx.doi.org/10.1042/bj1730857] [PMID: 30449]
[http://dx.doi.org/10.2307/3572046] [PMID: 4381270]
[http://dx.doi.org/10.1002/jlac.18852310102]
[http://dx.doi.org/10.1021/ja01464a021]
[http://dx.doi.org/10.1002/hlca.19570400327]
[http://dx.doi.org/10.1002/hlca.19580410715]
[PMID: 13130534]
[http://dx.doi.org/10.1021/ja01607a066]
[http://dx.doi.org/10.1021/jo01044a032]
[http://dx.doi.org/10.1016/0006-291X(64)90081-6 PMID: 4220836]
[http://dx.doi.org/10.1002/jlac.19687170111]
[http://dx.doi.org/10.1002/anie.197005231]
[http://dx.doi.org/10.1002/hlca.19370200107]
[http://dx.doi.org/10.1021/ja01184a094]
[http://dx.doi.org/10.1021/ja01132a008]
[http://dx.doi.org/10.1021/jo01051a505]
[http://dx.doi.org/10.1002/recl.19420610108]
[http://dx.doi.org/10.1002/recl.19420610607]
[http://dx.doi.org/10.1021/ja00898a010]
[http://dx.doi.org/10.1016/S0040-4039(01)84023-5]
[http://dx.doi.org/10.1002/jlac.19596210115]
[http://dx.doi.org/10.1021/ja01092a074]
[http://dx.doi.org/10.1002/jlac.19596210114]
[http://dx.doi.org/10.1039/C4OB00628C] [PMID: 25007896]
[http://dx.doi.org/10.1080/00397911.2013.825807]
[http://dx.doi.org/10.1007/s11164-012-0962-6]
[http://dx.doi.org/10.5012/bkcs.2012.33.8.2679]
[http://dx.doi.org/10.1021/jo400578m] [PMID: 23614840]
[http://dx.doi.org/10.1007/s13762-016-1037-9]
[http://dx.doi.org/10.1016/j.molcata.2013.11.010]
[http://dx.doi.org/10.1002/hlca.201500009]
[http://dx.doi.org/10.3184/174751913X13843392957323]
[http://dx.doi.org/10.1021/mz500734c]
[http://dx.doi.org/10.1002/adsc.201300810]
[http://dx.doi.org/10.1016/j.arabjc.2011.01.027]
[http://dx.doi.org/10.1039/c3gc40441b]
[http://dx.doi.org/10.1016/j.tetlet.2016.07.071]
[http://dx.doi.org/10.1016/j.dyepig.2018.08.018]
[http://dx.doi.org/10.1002/slct.201803559]
[http://dx.doi.org/10.1016/j.cattod.2017.05.038]
[http://dx.doi.org/10.1002/jccs.201500453]
[http://dx.doi.org/10.1016/j.bioorg.2018.11.009] [PMID: 30471487]
[http://dx.doi.org/10.1016/j.molstruc.2018.10.002]
[http://dx.doi.org/10.1016/j.ijbiomac.2016.09.012] [PMID: 27608546]
[http://dx.doi.org/10.1080/00397911.2017.1416638]
[http://dx.doi.org/10.1016/j.ijbiomac.2018.05.035] [PMID: 29751038]
[http://dx.doi.org/10.3390/molecules23102692] [PMID: 30347659]
[http://dx.doi.org/10.1021/acsomega.8b00379] [PMID: 31458714]